A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
Clinical trial NCT03641560 · COMPLETED
Trial details
- NCT number
- NCT03641560
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2024-02-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.